11/12/2024 2:50 PM | Karyopharm Therapeutics (Subject) VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
11/06/2024 3:06 PM | Karyopharm Therapeutics (Issuer) Paulson Richard A. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/05/2024 7:02 AM | Karyopharm Therapeutics (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
11/05/2024 6:47 AM | Karyopharm Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/05/2024 6:41 AM | Karyopharm Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/04/2024 10:49 AM | Karyopharm Therapeutics (Subject) VANGUARD GROUP INC (Filed by)
| Form SC 13G/A | |
10/31/2024 6:41 AM | Karyopharm Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
|
10/25/2024 8:30 AM | HIGHBRIDGE CAPITAL MANAGEMENT LLC (Filed by) Karyopharm Therapeutics (Subject)
| Form SC 13G | |
09/05/2024 3:28 PM | Karyopharm Therapeutics (Issuer) Mano Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/05/2024 3:13 PM | Cheng Sohanya Roshan (Reporting) Karyopharm Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/05/2024 3:24 PM | Karyopharm Therapeutics (Issuer) Mason Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/05/2024 3:26 PM | Karyopharm Therapeutics (Issuer) Paulson Richard A. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/29/2024 3:05 PM | Karyopharm Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/08/2024 3:31 PM | Karyopharm Therapeutics (Issuer) Paulson Richard A. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/06/2024 6:33 AM | Karyopharm Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/06/2024 6:42 AM | Karyopharm Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
07/31/2024 3:14 PM | Karyopharm Therapeutics (Issuer) Poulton Stuart (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/19/2024 3:07 PM | Karyopharm Therapeutics (Subject)
| Form SC TO-I/A | |
07/09/2024 3:15 PM | Karyopharm Therapeutics (Issuer) Paulson Richard A. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/08/2024 3:32 PM | BlackRock Inc. (Filed by) Karyopharm Therapeutics (Subject)
| Form SC 13G/A | |
06/20/2024 7:01 AM | Karyopharm Therapeutics (Subject)
| Form SC TO-I | |
06/09/2024 11:15 PM | Karyopharm Therapeutics (Filer)
| Form EFFECT | |
06/07/2024 6:18 PM | Karyopharm Therapeutics (Issuer) PAKIANATHAN DEEPIKA (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/04/2024 5:51 PM | Karyopharm Therapeutics (Issuer) PAKIANATHAN DEEPIKA (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/31/2024 7:00 AM | Karyopharm Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/30/2024 4:32 PM | Karyopharm Therapeutics (Issuer) Oliger Christy J. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/30/2024 4:19 PM | BOHLIN GAREN G (Reporting) Karyopharm Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/30/2024 4:25 PM | Greene Barry E (Reporting) Karyopharm Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/30/2024 4:32 PM | Karyopharm Therapeutics (Issuer) Mirza Mansoor Raza (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/30/2024 4:32 PM | Karyopharm Therapeutics (Issuer) PAKIANATHAN DEEPIKA (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/30/2024 4:32 PM | Karyopharm Therapeutics (Issuer) Schor Chen (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/30/2024 4:32 PM | Karyopharm Therapeutics (Issuer) Su Zhen (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/30/2024 3:44 PM | Karyopharm Therapeutics (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
05/14/2024 3:06 PM | Karyopharm Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/08/2024 3:13 PM | Karyopharm Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/08/2024 6:47 AM | Karyopharm Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/08/2024 6:52 AM | Karyopharm Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/07/2024 3:56 PM | Karyopharm Therapeutics (Issuer) Paulson Richard A. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/19/2024 6:55 AM | Karyopharm Therapeutics (Filer)
| Form ARS | |
04/19/2024 6:36 AM | Karyopharm Therapeutics (Filer)
| Form DEF 14A | |
04/19/2024 6:44 AM | Karyopharm Therapeutics (Filer)
| Form DEFA14A | |
Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners (Ad) The "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you.
A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners… Claim your FREE 2024 Gold Guide |
04/08/2024 4:08 PM | Karyopharm Therapeutics (Subject)
| Form SC TO-C | |
04/08/2024 3:40 PM | Karyopharm Therapeutics (Filer)
| Form PRE 14A | |
04/05/2024 4:20 PM | Karyopharm Therapeutics (Issuer) Paulson Richard A. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2024 6:36 PM | Karyopharm Therapeutics (Issuer) Paulson Richard A. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2024 6:37 PM | Cheng Sohanya Roshan (Reporting) Karyopharm Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2024 6:38 PM | Karyopharm Therapeutics (Issuer) Mano Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2024 6:39 PM | Karyopharm Therapeutics (Issuer) Mason Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2024 6:40 PM | Karyopharm Therapeutics (Issuer) Poulton Stuart (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/04/2024 6:41 PM | Karyopharm Therapeutics (Issuer) Rangwala Reshma (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/29/2024 4:34 PM | Karyopharm Therapeutics (Issuer) Paulson Richard A. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/29/2024 4:35 PM | Cheng Sohanya Roshan (Reporting) Karyopharm Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/29/2024 4:35 PM | Karyopharm Therapeutics (Issuer) Mano Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/29/2024 4:35 PM | Karyopharm Therapeutics (Issuer) Mason Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/29/2024 4:35 PM | Karyopharm Therapeutics (Issuer) Poulton Stuart (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/29/2024 4:36 PM | Karyopharm Therapeutics (Issuer) Rangwala Reshma (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/29/2024 6:43 AM | Karyopharm Therapeutics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/29/2024 6:35 AM | Karyopharm Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/20/2024 7:00 AM | Karyopharm Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/14/2024 9:33 AM | Avidity Partners Management LP (Filed by) Karyopharm Therapeutics (Subject)
| Form SC 13G/A | |
02/12/2024 5:06 AM | Karyopharm Therapeutics (Subject) Rubric Capital Management LP (Filed by)
| Form SC 13G/A | |
02/08/2024 3:36 PM | Karyopharm Therapeutics (Issuer) Mason Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/25/2024 6:40 PM | Cheng Sohanya Roshan (Reporting) Karyopharm Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/25/2024 5:43 PM | Karyopharm Therapeutics (Issuer) Paulson Richard A. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/25/2024 5:47 PM | Karyopharm Therapeutics (Issuer) Mason Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/25/2024 5:53 PM | Karyopharm Therapeutics (Issuer) Mano Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/25/2024 6:14 PM | Karyopharm Therapeutics (Issuer) Poulton Stuart (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/25/2024 6:16 PM | Karyopharm Therapeutics (Issuer) Rangwala Reshma (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/22/2024 12:50 PM | Karyopharm Therapeutics (Subject) STATE STREET CORP (Filed by)
| Form SC 13G/A | |
01/08/2024 8:00 PM | Karyopharm Therapeutics (Issuer) Paulson Richard A. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/08/2024 7:40 AM | Karyopharm Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/08/2023 7:00 AM | Karyopharm Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/08/2023 7:00 AM | Karyopharm Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/05/2023 4:03 PM | Karyopharm Therapeutics (Issuer) Paulson Richard A. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |